Provided by Tiger Trade Technology Pte. Ltd.

Caribou Biosciences

0.6028
-0.5322-46.89%
Volume:34.50M
Turnover:21.26M
Market Cap:64.50M
PE:-0.56
High:0.6700
Open:0.6200
Low:0.5460
Close:1.14
52wk High:3.54
52wk Low:0.5460
Shares:107.00M
Float Shares:102.16M
Volume Ratio:18.39
T/O Rate:33.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0751
EPS(LYR):-1.5900
ROE:-78.27%
ROA:-36.84%
PB:0.66
PE(LYR):-0.38

Loading ...

U.S. Stocks on the MOVE-Halozyme, BKV, AppFolio

Reuters
·
3 hours ago

Why is Caribou Biosciences Stock (CRBU) Down 43% Today?

TIPRANKS
·
Yesterday

Caribou Biosciences Price Target Cut to $1.00/Share from $4.00 by Leerink Partners

Dow Jones
·
Yesterday

U.S. Stocks on the MOVE-Intel, Vaxcyte, Constellation Brands

Reuters
·
Yesterday

Top Premarket Decliners

MT Newswires Live
·
Yesterday

RBC Downgrades Caribou Biosciences to Sector Perform From Outperform, Cuts Price Target to $1 From $10, Keeps Speculative Risk

MT Newswires Live
·
Yesterday

Stock Market Today: Dow Jones, Nasdaq 100 Futures Decline as Iran Mocks US Economy, Trump Sparks Bipartisan Backlash — STZ, PENG, LEVI in Focus

Benzinga Earnings
·
Yesterday

Caribou Plunges as it Explores Sale, Scraps Cancer Programs

Reuters
·
Yesterday

Levi Strauss, Constellation Brands and 3 Stocks to Watch Heading Into Wednesday

Benzinga Earnings
·
Yesterday

Caribou Biosciences, Inc. : Leerink Partners Cuts to Market Perform from Outperform; Cuts Target Price to $1 from $4

THOMSON REUTERS
·
Yesterday

Stocks to Watch: Constellation, Caribou, Penguin

Dow Jones
·
Yesterday

Caribou Falls After Scrapping Cell Therapy Programs, Launches Strategic Review

Reuters
·
Yesterday

Caribou Biosciences to End Drug Development, Cut Staff Due to Funding Problems

Dow Jones
·
Yesterday

Caribou Biosciences Shares Fall 38% to $0.70 After the Bell; Announced Discontinuing CAR-T Cell Therapy Programs, Evaluating Strategic Alternatives, Substantial Job Cuts

THOMSON REUTERS
·
Yesterday

Caribou Biosciences announces restructuring, explores strategic alternatives

TIPRANKS
·
Yesterday

Caribou Biosciences - Expects $10 Mln-$11 Mln in Severance, $5 Mln-$8 Mln for Clinical Trial Wind-Down - SEC Filing

THOMSON REUTERS
·
Yesterday

Caribou Biosciences Plans Major Workforce Reduction, Halts CAR-T Programs

Reuters
·
Yesterday

Caribou Biosciences to Evaluate Strategic Alternatives

THOMSON REUTERS
·
Yesterday

Caribou Biosciences - Reports Cash and Securities of $113.80 Mln as of June 30, 2026

THOMSON REUTERS
·
Yesterday

Caribou Biosciences - Plans Substantial Workforce Reduction Expected to be Mostly Complete in Q4 2026

THOMSON REUTERS
·
Yesterday